Chadwick, David <br/><br/>
Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.  [electronic resource] 

 -  BMJ (Clinical research ed.)  May 2003 
 - 1212-3 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1756-1833 
<br/><br/><label>Standard No.: </label>10.1136/bmj.326.7400.1212-a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Azathioprine--economics<br/>Cost-Benefit Analysis<br/>Humans<br/>Immunosuppressive Agents--economics<br/>Multiple Sclerosis--drug therapy<br/>Risk Sharing, Financial